{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:08:38Z","timestamp":1788876518322,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.reumae.2026.502211","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:22:48Z","timestamp":1788873768000},"page":"502211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Weight change patterns in rheumatoid arthritis patients treated with leflunomide: A real-world comparative study"],"prefix":"10.1016","volume":"22","author":[{"given":"Asadullah","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nazeer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabbey Raza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazila","family":"Nazeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakina","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2026.502211_bib0125","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.reumae.2026.502211_bib0130","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.reumae.2026.502211_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis: 2022 update","volume":"82","author":"Smolen","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2026.502211_bib0140","doi-asserted-by":"crossref","first-page":"e004387","DOI":"10.1136\/rmdopen-2024-004387","article-title":"Remission versus low disease activity as treatment targets in rheumatoid arthritis","volume":"10","author":"Duarte","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.reumae.2026.502211_bib0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.reuma.2017.07.020","article-title":"Systematic review and meta-analysis of the efficacy and safety of leflunomide and methotrexate in RA","volume":"15","author":"Alfaro-Lara","year":"2019","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reumae.2026.502211_bib0150","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/annrheumdis-2013-204588","article-title":"Efficacy of conventional synthetic DMARDs: systematic literature review for the 2013 EULAR update","volume":"73","author":"Gaujoux-Viala","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2026.502211_bib0155","first-page":"1182","article-title":"Leflunomide for the treatment of rheumatoid arthritis","volume":"30","author":"Osiri","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.reumae.2026.502211_bib0160","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/11316650-000000000-00000","article-title":"Benefit-risk assessment of leflunomide in rheumatoid arthritis 10 years after licensing","volume":"32","author":"Alcorn","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.reumae.2026.502211_bib0165","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/art.39647","article-title":"Changes in body mass related to the initiation of disease-modifying therapies in RA","volume":"68","author":"Baker","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.reumae.2026.502211_bib0170","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/1529-0131(200105)44:5<1048::AID-ANR184>3.0.CO;2-V","article-title":"Leflunomide-associated weight loss in rheumatoid arthritis","volume":"44","author":"Coblyn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2026.502211_bib0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/metabo14110645","article-title":"Leflunomide-induced weight loss: involvement of DAHPS activity and synthesis of aromatic amino acids","volume":"14","author":"Guo","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/j.reumae.2026.502211_bib0180","first-page":"396","article-title":"Mitochondrial dysfunction induced by leflunomide and its active metabolite","volume":"33","author":"Xuan","year":"2018","journal-title":"Toxicology"},{"key":"10.1016\/j.reumae.2026.502211_bib0185","first-page":"80","article-title":"Effectiveness and safety profile of leflunomide in rheumatoid arthritis: actual practice compared with clinical trials","volume":"23","author":"Martin","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reumae.2026.502211_bib0190","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/1756-185X.13184","article-title":"Disease activity trajectories in early RA following intensive DMARD therapy","volume":"20","author":"Wabe","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.reumae.2026.502211_bib0195","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/s41598-022-05644-7","article-title":"Therapeutic response to leflunomide in combo therapy and monotherapy","volume":"12","author":"Fajardo-Robledo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.reumae.2026.502211_bib0200","doi-asserted-by":"crossref","first-page":"e70068","DOI":"10.1002\/msc.70068","article-title":"Impact of disease duration and onset pattern on treatment delays and progression of rheumatoid arthritis: insights from a Pakistani cohort","volume":"23","author":"Khan","year":"2025","journal-title":"Musculoskeletal Care"},{"key":"10.1016\/j.reumae.2026.502211_bib0205","unstructured":"Zaidi S, Bhutta Z, Qazi S, et al. Baluchistan province report: nutrition political economy, Pakistan institute of development studies (MQSUN report)."},{"key":"10.1016\/j.reumae.2026.502211_bib0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003653","article-title":"Subnational tuberculosis burden estimation for Pakistan","volume":"4","author":"Schwalb","year":"2024","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.reumae.2026.502211_bib0215","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jcsm.12320","article-title":"Prevalence of rheumatoid cachexia in rheumatoid arthritis","volume":"9","author":"Santo","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.reumae.2026.502211_bib0220","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/ar2658","article-title":"Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century","volume":"11","author":"Roubenoff","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.reumae.2026.502211_bib0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2014.00020","article-title":"Rheumatoid cachexia revisited: a metabolic co-morbidity in rheumatoid arthritis","volume":"1","author":"Masuko","year":"2014","journal-title":"Front Nutr"},{"key":"10.1016\/j.reumae.2026.502211_bib0230","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/rheumatology\/ken146","article-title":"Rheumatoid cachexia: a clinical perspective","volume":"47","author":"Summers","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.reumae.2026.502211_bib0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-020-00933-4","article-title":"The impact of obesity on disease activity and treatment response in rheumatoid arthritis","volume":"22","author":"Poudel","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.reumae.2026.502211_bib0240","doi-asserted-by":"crossref","first-page":"e0195123","DOI":"10.1371\/journal.pone.0195123","article-title":"Obesity and response to anti-TNF agents in immune-mediated inflammatory diseases","volume":"13","author":"Singh","year":"2018","journal-title":"PLOS ONE"}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173574326001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:23:21Z","timestamp":1788873801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173574326001140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2173574326001140"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502211","relation":{},"ISSN":["2173-5743"],"issn-type":[{"value":"2173-5743","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weight change patterns in rheumatoid arthritis patients treated with leflunomide: A real-world comparative study","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2026.502211","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2026.502211","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"502211"}}